RxDoctor Payments Data

Jilian Thomas, PA

Physician Assistant · Greenville, SCNPI 1598003436

Payments from drug & device makers

$6,337in general payments, 2019–2025

Across 372 payments — averaging $17.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • AstraZeneca$751
  • Novo Nordisk$515
  • Amgen$459
  • Takeda Pharmaceuticals U.S.A., Inc.$261
  • Amarin Pharma, Inc.$258
  • plus $3K from 36 others

What the payments were for

  • Food & beverage$6,337100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,337 in reported general payments places this provider in the 90th percentile of 1,852 physician assistant providers in South Carolina.

See all physician assistant providers in South Carolina

Medicare billing

Part B allowed, 2024
$26,287
Medicare patients
43
Services billed
1,049

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol21$15,313
Bupropion XlBupropion Hcl15$1,275
Duloxetine Hcl11$1,015
Rosuvastatin Calcium46$938
Tamsulosin Hcl13$555
Atorvastatin Calcium44$419
Levothyroxine Sodium31$390
Methocarbamol15$370
Losartan Potassium16$356
Omeprazole19$289
Risperidone11$288
Amitriptyline Hcl11$242
Fluticasone Propionate17$230
Potassium Chloride11$213
Metoprolol Succinate13$208

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$751$15,31321 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,852 physician assistant providers in South Carolina.

Other physician assistant in Greenville

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →